Innovation in China Through Collaborative Research Organization(CRO)

来源 :亚太药物研发领袖峰会(Asia Pharma R&D Leaders Summit 2018) | 被引量 : 0次 | 上传用户:t272162898
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BIODURO The Spring is here! The Spring of Drug Discovery in China is here Talents Policy Money Entrepreneurship Basic research
其他文献
血栓性疾病和危害血栓性疾病是指由于血栓形成导致血管堵塞所引起的相应器官组织病变、坏死,相应功能障碍及损坏等多种疾病总称.30年来血栓性疾病导致的死亡率一直占总疾病死
会议
主要内容质谱检测技术简介质谱临床运用现状蛋白组/代谢组检测临床运用的潜力蛋白组/代谢组临床运用存在的问题南芯医疗:在蛋白组/代谢组检测的进展临床检验基本内容
会议
Radiation Detection Instruments (1)Scintillation Detector (ZnS(Ag))Treatment priority Medical treatment for serious conditions always take precedence over decon
会议
核事故医学应急面临的形式和任务1.核电站的发展:2.核燃料循环的发展:核电站的建设,带动了核燃料循环的快速发展,一批相应的核燃料生产设施和核废料后处理设施也要建设.3.核
会议
Outline· Past-There was no guidance in those early years -Mainly conducted BE trials of generic drugs -Generic PK trials of imported drugs requested by SFDA ·
会议
Contents 1.Brief history of pharmacometrics in China 1979-2000: PD, PK, statistical model 2000-2015: PPK, PK-PD, MBMA 2.China status of pharmacometrics only pre
会议
Outline · Trends in globalization of clinical drug development and ethnicity focused regulatory environment · Mechanisms for ethnic differences in drug respon
会议
Content 1.Use of PPK, PK/PD in clinical research of antimicrobial agents 2.PPK and PK/PD guide optimization of treatment regimen 3.PPK and PK/PD guide treatment
会议
·Drug development decision makers need In rely on robust rationale to select drug candidates, targets, trial designs, dose regimens, patient populations and su
会议
Cancer therapy PD of Irreversible Effects: Phase-nonspecific PD of Irreversible Effects: Phase-nonspecific PD of Irreversible Effects: Cell-cycle Specific
会议